New research released from the Society for your Study of Addiction produced positive news about two prescription drugs used to assist in preventing lapse in alcoholics in treatment trying to stay sober. The drugs, acamprosate (marketing name: Campral) and naltrexone (ReVia) were found to help you those struggling in various phases of recovery. Acamprosate helped manage emotional triggers in people that had already stopped drinking, naltrexone helped manage cravings in heavy drinkers who are attempting to stop drinking or recently quit. Using two separate drugs to lose weight can be very effective you will find combinations while watching FDA now awaiting approval. When dealing with weight reduction and the people that go through it one should err assisting caution and allow FDA do its job and demand some investigation be done so your public understands the side effects and risks of the medications before we bring them. Keep in mind that drug companies have been in business to generate income and that they would say everything to keep people on their medications. Researchers discovered that participants using this drug to get a year, dropped excess weight within one month and have kept the weight off through the entire 56 weeks of the study. Contrave can be a combination of the drugs naltrexone and bupropion, which generally seems to reflect a whole new trend of weight-loss drugs which might be made up of more than one active ingredient, that might make them more effective and safer. Combo-pilling is the newest fad or better yet the newest into the future under scrutiny and thus it is just more publicly known recently, comb-pilling to lose weight has been around since the eighties. The biggest reason that using a combination of pills is becoming popular could be the fact that at the time of right now there are no long term prescription diet pills that have been licensed by the FDA besides orlistat. The truly disturbing part is the fact that doctors are prescribing these combinations of medications even though some of the combinations have been rejected or have yet to be authorized by the FDA. Seizures can be a side effect with Contrave and really should not be taken in individuals with seizure disorders. The drug may also raise blood pressure levels and heart rate, and shouldn't be used in individuals with a history of cardiac arrest or stroke in the last six months. Blood pressure and pulse should also be measured prior to starting the drug and throughout therapy with the drug. The FDA also warned that Contrave can raise hypertension and heart rate and must not be used in patients with uncontrolled high blood pressure level, along with by you are not heart-related and cerebrovascular (circulation dysfunction impacting mental performance) disease. Patients using a history of heart attack or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded through the clinical trials. Those taking Contrave really should have their heart-rate and pulse monitored regularly. In addition, considering that the compound includes bupropion, Contrave comes with a boxed warning to alert medical researchers and patients on the increased chance of suicidal thoughts and behaviors related to antidepressant drugs. The warning also notes that serious neuropsychiatric events happen to be reported in patients taking bupropion for stopping smoking. Approving a drug with this many potentially lethal unwanted side effects is inconsistent with all the mission statement of the FDA. The power in the drug manufacturing lobby is blatantly evident inside the approval of many drugs requiring 'post-marketing' studies that are clearly significant to overall drug safety inside the US.